Chile · Delayed Price · Currency is CLP Coca-Cola Embonor Statistics
Total Valuation
SNSE:EMBONOR.A has a market cap or net worth of CLP 699.60 billion. The enterprise value is 910.88 billion.
| Market Cap | 699.60B |
| Enterprise Value | 910.88B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | Nov 12, 2025 |
Share Statistics
SNSE:EMBONOR.A has 510.85 million shares outstanding.
| Current Share Class | 244.42M |
| Shares Outstanding | 510.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.28% |
| Float | 204.05M |
Valuation Ratios
The trailing PE ratio is 9.55.
| PE Ratio | 9.55 |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| PB Ratio | 1.29 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | 12.85 |
| P/OCF Ratio | 6.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of 16.74.
| EV / Earnings | 12.81 |
| EV / Sales | 0.68 |
| EV / EBITDA | 4.99 |
| EV / EBIT | 7.84 |
| EV / FCF | 16.74 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.72 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 1.85 |
| Debt / FCF | 6.17 |
| Interest Coverage | 6.24 |
Financial Efficiency
Return on equity (ROE) is 13.03% and return on invested capital (ROIC) is 7.92%.
| Return on Equity (ROE) | 13.03% |
| Return on Assets (ROA) | 6.38% |
| Return on Invested Capital (ROIC) | 7.92% |
| Return on Capital Employed (ROCE) | 13.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.19 |
| Inventory Turnover | 6.74 |
Taxes
In the past 12 months, SNSE:EMBONOR.A has paid 26.77 billion in taxes.
| Income Tax | 26.77B |
| Effective Tax Rate | 27.35% |
Stock Price Statistics
The stock price has increased by +10.83% in the last 52 weeks. The beta is 0.05, so SNSE:EMBONOR.A's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +10.83% |
| 50-Day Moving Average | 1,330.00 |
| 200-Day Moving Average | 1,299.59 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | 138 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:EMBONOR.A had revenue of CLP 1.35 trillion and earned 71.13 billion in profits. Earnings per share was 139.23.
| Revenue | 1.35T |
| Gross Profit | 494.41B |
| Operating Income | 115.85B |
| Pretax Income | 97.90B |
| Net Income | 71.13B |
| EBITDA | 178.71B |
| EBIT | 115.85B |
| Earnings Per Share (EPS) | 139.23 |
Balance Sheet
The company has 124.75 billion in cash and 336.00 billion in debt, giving a net cash position of -211.25 billion or -413.52 per share.
| Cash & Cash Equivalents | 124.75B |
| Total Debt | 336.00B |
| Net Cash | -211.25B |
| Net Cash Per Share | -413.52 |
| Equity (Book Value) | 543.00B |
| Book Value Per Share | 1,062.88 |
| Working Capital | 159.32B |
Cash Flow
In the last 12 months, operating cash flow was 110.17 billion and capital expenditures -55.75 billion, giving a free cash flow of 54.43 billion.
| Operating Cash Flow | 110.17B |
| Capital Expenditures | -55.75B |
| Free Cash Flow | 54.43B |
| FCF Per Share | 106.54 |
Margins
Gross margin is 36.65%, with operating and profit margins of 8.59% and 5.27%.
| Gross Margin | 36.65% |
| Operating Margin | 8.59% |
| Pretax Margin | 7.26% |
| Profit Margin | 5.27% |
| EBITDA Margin | 13.25% |
| EBIT Margin | 8.59% |
| FCF Margin | 4.03% |
Dividends & Yields
This stock pays an annual dividend of 83.80, which amounts to a dividend yield of 6.30%.
| Dividend Per Share | 83.80 |
| Dividend Yield | 6.30% |
| Dividend Growth (YoY) | -36.54% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 60.36% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.30% |
| Earnings Yield | 10.17% |
| FCF Yield | 7.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:EMBONOR.A has an Altman Z-Score of 2.94 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 8 |